…I agree with previous comments [#msg-54966129] that the inspection is necessary for a Teva approval but not sufficient. Also, if I'm not mistaken, Teva has manufacturing facilities as part of their empire. In that respect, it's not really surprising that they've had a successful appraisal of their plant(s).
It’s notable that Teva has never revealed where its version of Lovenox is manufactured or even disclosed whether Teva itself performs the manufacturing. This is in sharp contrast to NVS, who disclosed a long time ago that it manufactures generic Lovenox at its own facility in Kundl, Austria.
Teva’s lack of candor on this subject makes me wonder what they might be hiding.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”